1 |
Shiloah J, Patters MR. Repopulation of periodontal pockets by microbial pathogens in the absence of supportive therapy. J Periodontol 1996;67:130-9.
DOI
|
2 |
Petersilka GJ, Ehmke B, Flemmig TF. Antimicrobial effects of mechanical debridement. Periodontol 2000 2002;28:56-71.
DOI
|
3 |
Greenstein G. Periodontal response to mechanical non-surgical therapy: a review. J Periodontol 1992;63:118-30.
DOI
|
4 |
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-44.
DOI
|
5 |
Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol 2012;27:409-19.
DOI
|
6 |
Adair JG. The Hawthorne effect: a reconsideration of the methodological artifact. J Appl Psychol 1984;69:334-45.
DOI
|
7 |
Coleman MA, inventor; Ovimmune, Inc., assignee. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants. United States patent US 5,585,098. 1996 Dec 17.
|
8 |
Sanz M, van Winkelhoff AJ. Periodontal infections: understanding the complexity--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011;38 Suppl 11:3-6.
DOI
|
9 |
Corbet EF, Leung WK. Epidemiology of periodontitis in the Asia and Oceania regions. Periodontol 2000 2011;56:25-64.
DOI
|
10 |
Dye BA. Global periodontal disease epidemiology. Periodontol 2000 2012;58:10-25.
DOI
|
11 |
Grenier D, Mayrand D. Periodontitis as an ecological imbalance. In: Kuramitsu HK, Ellen RP, editors. Oral bacterial ecology: the molecular basis. Wymondham: Horizon Scientific; 2000. p.275-310.
|
12 |
Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 1999;20:82-121.
DOI
|
13 |
Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999;20:168-238.
DOI
|
14 |
Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett 2012;333:1-9.
DOI
|
15 |
Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002;28:106-76.
DOI
|
16 |
Handal T, Caugant DA, Olsen I. Antibiotic resistance in bacteria isolated from subgingival plaque in a Norwegian population with refractory marginal periodontitis. Antimicrob Agents Chemother 2003;47:1443-6.
DOI
|
17 |
James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev 2017;3:CD008676.
|
18 |
Xu FX, Xu YP, Jin LJ, Liu H, Wang LH, You JS, et al. Effectiveness of egg yolk immunoglobulin (IgY) against periodontal disease-causing Fusobacterium nucleatum. J Appl Microbiol 2012;113:983-91.
DOI
|
19 |
Klemperer PF. Ueber naturliche immunitat und ihre verwerthung fur die immunisirungstherapie. Arch Exp Pathol Pharmakol 1893;31:356-82.
DOI
|
20 |
Schade R, Hlinak A. Egg yolk antibodies, state of the art and future prospects. ALTEX 1996;13:5-9.
|
21 |
Yokoyama K, Sugano N, Rahman AK, Oshikawa M, Ito K. Activity of anti-Porphyromonas gingivalis egg yolk antibody against gingipains in vitro. Oral Microbiol Immunol 2007;22:352-5.
DOI
|
22 |
Nilsson E, Larsson A, Olesen HV, Wejaker PE, Kollberg H. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr Pulmonol 2008;43:892-9.
DOI
|
23 |
Suzuki H, Nomura S, Masaoka T, Goshima H, Kamata N, Kodama Y, et al. Effect of dietary anti Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Aliment Pharmacol Ther 2004;20 Suppl 1:185-92.
DOI
|
24 |
Wilhelmson M, Carlander D, Kreuger A, Kollberg H, Larsson A. Oral treatment with yolk antibodies for the prevention of C. albicans infections in chemotherapy treated children. A feasibility study. Food Agric Immunol 2005;16:41-5.
DOI
|
25 |
Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
DOI
|
26 |
World Medical Association General Assembly. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique 2004;15:124-9.
DOI
|
27 |
Yokoyama K, Sugano N, Shimada T, Shofiqur RA, Ibrahim ES, Isoda R, et al. Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients. J Oral Sci 2007;49:201-6.
DOI
|
28 |
Loe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610-6.
DOI
|
29 |
Schade R, Calzado EG, Sarmiento R, Chacana PA, Porankiewicz-Asplund J, Terzolo HR. Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern Lab Anim 2005;33:129-54.
|
30 |
Sugano N. Adjunctive effects of anti-porphyromonas gingivalis egg yolk antibody with scaling and root planing: a randomized, placebo-controlled clinical trial. J Periodontol 2009;80:1901-3.
DOI
|
31 |
Plessas A. Nonsurgical periodontal treatment: review of the evidence. Oral Health Dent Manag 2014;13:71-80.
|
32 |
Muller HP, Hartmann J, Flores-de-Jacoby L. Clinical alterations in relation to the morphological composition of the subgingival microflora following scaling and root planing. J Clin Periodontol 1986;13:825-32.
DOI
|
33 |
Xu Y, Li X, Jin L, Zhen Y, Lu Y, Li S, et al. Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: a review. Biotechnol Adv 2011;29:860-8.
DOI
|
34 |
Hanes PJ, Purvis JP. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol 2003;8:79-98.
DOI
|
35 |
Socransky SS, Haffajee AD, Teles R, Wennstrom JL, Lindhe J, Bogren A, et al. Effect of periodontal therapy on the subgingival microbiota over a 2-year monitoring period. I. Overall effect and kinetics of change. J Clin Periodontol 2013;40:771-80.
DOI
|